The FDA has approved lenacapavir, a groundbreaking antiviral drug for HIV prevention developed by biochemist Wesley Sundquist. Learn how this drug could change the future of HIV treatment and prevention.
A groundbreaking HIV prevention shot, Yeztugo, has been approved by the FDA, offering hope for at-risk individuals with its twice-yearly injections. However, concerns about cost and accessibility remain.
New research reveals that HIV drugs known as NRTIs can reduce the risk of developing Alzheimer’s disease by 6% to 13% annually. Scientists urge for clinical trials to explore this promising link.
Johns Hopkins University has announced over 2,000 layoffs globally after losing $800 million in federal grants. The cuts, largely stemming from the Trump administration's funding reductions, will impact critical health programs and local economies.
